IDFC CRISIL IBX 90:10 SDL Plus Gilt - April 2032 Index Fund - Direct Plan

Our Funds / ETF/Index Funds

IDFC CRISIL IBX 90:10 SDL Plus Gilt - April 2032 Index Fund - Direct Plan

An open-ended Target Maturity Index Fund investing in constituents of CRISIL IBX 90:10 SDL plus Gilt Index – April 2032 with Relatively High Interest Rate Risk and Relatively Low Credit Risk

NFO Period: 14th November 2022 to 28th November 2022

ETF/IndexInception Date:29/11/2022
Ask an Advisor

This Target Maturity Index Fund aims to provide the investment returns corresponding to the total returns of the securities as represented by the CRISIL IBX 90:10 SDL plus Gilt Index – April 2032 before expenses, subject to tracking errors. The scheme will terminate on 30th April 2032

  • Min Investment 5,000
  • Min SIP Amount 1,000
  • Exit Load

    Nil

Select

This scheme has not completed one year.

NAV undefined as on undefined1 Day Change: (undefined)

Scheme is suitable for a 3 years+ investment horizon

Tier 1 Benchmark : CRISIL IBX 90:10 SDL plus Gilt Index - April 2032Alternate Benchmark : Crisil 10 Year GOI

This is a new scheme and required performance data is not yet available.

This fund is managed by Mr. Gautam Kaul (w.e.f 29/11/2022) & Harshal Joshi (w.e.f 29/11/2022)

View fund performance of other funds managed by Mr. Gautam Kaul, Harshal Joshi

Past performance may or may not be sustained in future.
Regular and Direct Plans have different expense structure. Direct Plan shall have a lower expense ratio excluding distribution expenses, commission expenses etc.

Taxation:

For taxation, please refer the link :  https://bit.ly/3a5CcbE

IDFC CRISIL IBX 90:10 SDL Plus Gilt April 2032 Index Fund

(Scheme Risk-o-meter)

Investors understand that their principal will be at Moderate Risk.

CRISIL IBX 90:10 SDL plus Gilt Index - April 2032

(Tier 1 Benchmark Risk-o-meter)

This product is suitable for investors who are seeking* :

  • Income over the target maturity period
  • Investment in constituents  CRISIL IBX 90:10 SDL plus Gilt Index – April 2032

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.